Please fill in the form below and one of the team will be in contact shortly.
Register here for the
latest AKU news.
Reach out to other AKU communities around the UK
Our staff are happy to hear from you.
DevelopAKUre is a series of major international clinical trials, run by a consortium of 12 European partners. It aims to study a potential new drug, called nitisinone, and assess its potential effectiveness in treating the rare disease, alkaptonuria (AKU).
DevelopAKUre is co-funded by a grant from the European Commission. This website is run by a UK patient group, the AKU Society. Learn more about AKU on the AKU Society's What is AKU page.
In today’s blog Chief investigator Prof. Ranganath reinforces the need for SONIA 2 pat.. ...more
In this week's blog, we talk to Brendan Norman, a PhD student at the University Of Liverpool, ab.. ...more